ARCA biopharma Inc

NASDAQ:ABIO   3:59:50 PM EDT
3.16
-0.25 (-7.33%)
Products, Regulatory

ARCA Biopharma Provides Update On ASPEN-COVID-19 Phase 2B Clinical Trial

Published: 07/13/2021 12:21 GMT
ARCA biopharma Inc (ABIO) - Arca Biopharma Provides Update on Aspen-covid-19 Phase 2b Clinical Trial Evaluating Rnapc2 As a Potential Treatment for Covid-19.
Arca Biopharma Inc - Trial Expanded to South America, With Regulatory Approvals for Argentina and Brazil.
Arca Biopharma Inc - Rnapc2 Development Focused on Unmet Need for Treatments in Hospitalized Covid-19 Patients.
Arca Biopharma Inc - Target Trial Enrollment Increased to 160 Patients.
Arca Biopharma Inc - Topline Trial Data Anticipated in Q4 of 2021.